Ascend Corporate Service Pte Ltd-Accounting Services Singapore

17/09/2026

Nominee Director in Singapore: Responsibilities, Duties and Risks

Foreign entrepreneurs establishing a Singapore company must appoint at least one director who is ordinarily resident in Singapore. Where the foreign shareholder does not have a suitable local director, a professional nominee director may be appointed to satisfy this statutory requirement.

However, a nominee director is not merely a “name on the company record”. Under Singapore law, a nominee director is a full legal director and generally has the same statutory and fiduciary duties as any other director.

What Is a Nominee Director?

A nominee director is an individual appointed to the board of a company on behalf of another person, usually the company’s shareholder or beneficial owner.

The nominee director may satisfy the local residency requirement, but the appointment does not transfer management responsibility away from the company’s owners. The shareholder remains responsible for properly operating and funding the business, while the nominee director must independently discharge their legal duties.

A nominee arrangement also does not permit the nominee director to blindly follow the shareholder’s instructions.

Main Responsibilities of a Nominee Director
1. Acting honestly and in the company’s interests

A nominee director must act honestly, exercise reasonable diligence and consider the interests of the company.

Although the director was nominated by a shareholder, the director’s duties are owed to the company—not solely to the person who appointed them. The nominee director should not approve a transaction merely because the shareholder has requested it.

2. Understanding the company’s business

The nominee director should have a reasonable understanding of:

The company’s business activities;
Its sources of income and funding;
Its customers, suppliers and major transactions;
Its accounting and financial position;
The identity of its shareholders and beneficial owners; and
The countries in which it conducts business.

A nominee director should request supporting information and raise questions where a transaction appears unusual, inconsistent or commercially unreasonable.

3. Monitoring statutory compliance

The director should take reasonable steps to ensure that the company complies with its statutory obligations, including:

Filing its annual returns with ACRA;
Maintaining proper accounting records;
Preparing financial statements where required;
Holding annual general meetings or passing the necessary written resolutions;
Filing corporate income tax returns with IRAS;
Registering for and filing GST where applicable;
Maintaining statutory registers and supporting records; and
Keeping the company’s registered particulars updated.

Appointing a company secretary or accountant does not completely remove the director’s responsibility to supervise the company’s compliance.

4. Reviewing documents before approval

A nominee director should not sign blank, incomplete or unexplained documents.

Before approving board resolutions, contracts, bank instructions, financial statements, loans, dividends or share transactions, the director should understand their nature and obtain sufficient supporting information.

5. Managing conflicts of interest

The director should disclose any direct or indirect interest in a transaction involving the company and avoid using the position for personal benefit.

Where the interests of the shareholder conflict with those of the company, the nominee director must exercise independent judgment and prioritise the company’s interests.

6. Monitoring the company’s financial condition

Directors must pay particular attention when a company experiences cash-flow problems or may become insolvent.

A nominee director should not permit the company to incur debts without a reasonable basis for believing that they can be paid. If insolvency is suspected, the director should obtain professional advice and consider the interests of creditors.

Key Risks Faced by a Nominee Director
Personal civil liability

A nominee director may be personally liable where a breach of duty causes loss to the company, its shareholders or creditors. The company may seek compensation or recovery of improperly obtained benefits.

Criminal and regulatory liability

A director may face investigation, prosecution, fines or disqualification for offences involving:

False or misleading filings;
Failure to maintain proper accounting records;
Serious or repeated statutory non-compliance;
Fraudulent or wrongful trading;
Tax offences;
Money laundering or dealing with criminal proceeds; and
Transactions that breach sanctions or other regulatory requirements.

The statement “I was only a nominee director” is generally not a defence.

Disqualification from acting as a director

Repeated filing defaults, insolvency-related misconduct, fraud or other breaches may result in the individual being disqualified from acting as a company director.

Banking and financial risks

A nominee director should be extremely cautious before becoming a bank signatory, approving loans, giving personal guarantees or authorising transfers.

The director should not allow their personal address, telephone number or banking access to be used to conceal the actual controller of the company.

Reputational risk

If the company becomes involved in fraud, sanctions violations, unpaid debts, illegal activities or regulatory investigations, the nominee director’s professional reputation may be seriously affected even if the director did not receive the financial benefits.

Risks for Shareholders Using a Nominee Director

The shareholder or beneficial owner also faces significant risks if the nominee arrangement is not properly managed.

These may include:

Delays in obtaining approval for unusual or unsupported transactions;
Suspension or termination of nominee director services;
Resignation of the nominee director where compliance concerns arise;
Reporting of suspicious transactions where legally required;
Difficulty opening or maintaining corporate bank accounts;
Regulatory investigation of the company and its beneficial owners; and
Additional costs involved in appointing a replacement director.

A nominee director must not be used to hide beneficial ownership, bypass regulatory requirements or create a false impression that the business is locally managed.

Register of Nominee Directors

A Singapore company must maintain the prescribed information concerning its nominee directors and the persons who nominated them. Relevant information must also be submitted to ACRA in accordance with the applicable filing requirements.

The nominee director should promptly provide the company with the required particulars and notify the company of any changes.

Certain information may not be publicly displayed in an ordinary business profile, but it remains available to ACRA and other authorised public agencies for regulatory and law-enforcement purposes.

Enhanced Regulation of Nominee Director Arrangements

The Corporate Service Providers Act 2024 came into effect on 9 June 2025. Among other requirements, a person who carries on a business of arranging for another person to act as a nominee director must be a registered corporate service provider.

Before arranging a nominee director, the corporate service provider must assess whether the proposed individual is fit and proper. These measures are intended to strengthen corporate transparency and reduce the misuse of nominee directorships.

More information is available from the Accounting and Corporate Regulatory Authority and in the Singapore Companies Act 1967 and Corporate Service Providers Act 2024.

How Can the Risks Be Managed?

A properly administered nominee director arrangement should include:

Comprehensive customer due diligence and beneficial-owner verification;
A written nominee director service agreement;
Clear restrictions on the nominee director’s authority;
Regular accounting and compliance reporting;
Timely access to bank statements and supporting documents;
Prior approval for material or high-risk transactions;
Ongoing screening for sanctions and adverse information;
Immediate disclosure of changes in business activities or ownership;
Adequate professional indemnity or directors’ and officers’ insurance, where appropriate; and
A clear resignation and replacement procedure.

The shareholder should cooperate fully and provide complete, accurate and timely information. Failure to do so may require the nominee director or corporate service provider to suspend or terminate the arrangement.

Conclusion

A nominee director service can help foreign entrepreneurs satisfy Singapore’s local-director requirement, but it is not a purely administrative appointment.

The nominee director assumes genuine legal responsibilities and must exercise independent judgment, monitor compliance and take reasonable steps to understand the company’s activities. The shareholder must therefore maintain transparent operations and work with a properly registered and experienced corporate service provider.

Ascend Corporate Service Pte. Ltd. is an ACRA-registered Corporate Service Provider. We provide Singapore company incorporation, corporate secretarial, accounting, tax and nominee local director services, subject to customer due diligence, risk assessment and ongoing compliance requirements.

Contact us to discuss whether a nominee director arrangement is suitable for your Singapore company.

Disclaimer: This article provides general information only and does not constitute legal, tax or regulatory advice. Professional advice should be obtained based on the specific facts and circumstances of each case.

Call now to connect with business.

31/08/2026

Tax Treatment of Insurance Premiums for Directors and Employees in Singapore

When a company pays insurance premiums for its directors or employees, the tax treatment depends on the type of policy, the beneficiary, whether the insured person is entitled to receive the payout and whether the policy has an investment or surrender value.

The company must consider three separate tax questions:

Is the insurance premium deductible for corporate income tax?
Is the premium a taxable benefit in the hands of the director or employee?
Can the company claim the GST charged on the premium?
This guide explains the treatment based on current Inland Revenue Authority of Singapore (IRAS) guidelines.

General Tax Treatment of Staff Insurance Premiums
Insurance premiums paid for employees are generally deductible as staff costs when they are incurred for the company’s business.

However, deductibility does not automatically mean that the premium is tax-free for the employee. If the employee or director receives insurance protection as an employment benefit, the premium may need to be reported as a taxable benefit-in-kind.

The policyholder, beneficiary, payout arrangement and terms of the employment contract must therefore be reviewed before deciding the tax treatment.

Summary of the Tax Treatment
Type of insurance Corporate tax treatment Taxable to director or employee?
Group medical insurance available to all staff Deductible, subject to the medical expense cap Generally not taxable
Individual medical or life insurance benefiting a director or employee Generally deductible as staff cost, subject to applicable restrictions Generally taxable
Group life, personal accident or critical illness insurance where employees are contractually entitled to the payout Generally deductible as staff cost Premium attributable to the employee is generally taxable
Group insurance where the employer is not contractually required to pass the payout to employees Generally deductible as staff cost Premium is generally not taxable
Business travel insurance Generally deductible Not taxable
Work injury compensation insurance Deductible Not taxable
Keyman insurance covering loss of company profits Generally deductible if revenue in nature No personal benefit if the company is the beneficiary
Insurance with investment or cash surrender value Generally capital and non-deductible Depends on who receives the benefit
Personal insurance of a shareholder-director with no genuine employment or business purpose May be non-deductible May be taxable as a benefit or other payment
Group Medical Insurance
Premiums for group medical insurance may qualify as deductible medical expenses for the company.

Under an IRAS administrative concession, the premium is generally not taxable in the hands of employees where:

The insurance is provided in place of medical costs that the employer would otherwise reimburse; and
The benefit is available to all staff.
The “available to all staff” condition is important. A medical policy provided only to selected directors or shareholders may not qualify for this concession unless there is a proper employment basis and the arrangement can be commercially justified.

IRAS explains the employee-level treatment in its guidance on insurance premiums paid by employers.

Corporate Tax Deduction Cap for Medical Insurance
Medical and dental insurance premiums are included within the company’s medical expense deduction limit.

The general deduction cap is:

1% of total employee remuneration; or
2% of total employee remuneration if the company implements qualifying portable medical benefits arrangements or meets the relevant conditions.
Total employee remuneration generally includes:

Employees’ salaries;
Allowances and bonuses;
Employer CPF contributions;
Directors’ executive remuneration; and
Mandatory overseas pension or provident fund contributions.
However, directors’ fees are excluded when calculating total employee remuneration for the medical expense cap.

This distinction is important where a company has directors but few or no employees. A company cannot use directors’ fees to increase the medical expense deduction limit, although executive remuneration paid to a working director may be included.

Further details are available in the IRAS guidance on the tax deduction for medical expenses.

Individual Insurance Policies for Directors or Employees
If a company pays the premium for an individual life, medical, accident or critical illness policy and the director or employee is the beneficiary, the insurance protection is generally a taxable employment benefit.

The premium paid by the company should generally be:

Included in the employee’s taxable income;
Reported in the employee’s Form IR8A, where applicable; and
Treated as staff cost by the company, subject to the normal deduction rules.
For example, if a company pays an annual personal life insurance premium of S$5,000 for its managing director and the director’s family is entitled to the payout, the S$5,000 would generally constitute a taxable benefit provided to the director.

The position is particularly sensitive where the insured person is also a shareholder. The company should be able to demonstrate that the premium forms part of a genuine employment remuneration package rather than a private or shareholder expense.

Group Life, Personal Accident or Critical Illness Insurance
The treatment of a group insurance policy depends largely on whether the employee is entitled to the insurance payout.

Employee Is Entitled to the Payout
The employee is treated as receiving an insurance benefit if:

The employee is the named beneficiary;
The employee’s nominated beneficiary or next-of-kin is entitled to the payout; or
The employer is contractually required to pass the payout to the employee or the employee’s beneficiaries.
The contractual obligation may appear in:

The employment contract;
The staff handbook;
The company’s human resources policy;
A collective agreement; or
The insurance policy itself.
In these circumstances, the portion of the premium attributable to the employee is generally taxable as an employment benefit.

Employer Has Discretion Over the Payout
The premium is generally not taxable to the employee where:

The employer is the policyholder and beneficiary;
The employee is not the named beneficiary; and
The employer has no contractual obligation to pass the payout to the employee, family or next-of-kin.
In this case, the employee has not received an enforceable insurance benefit.

However, if the employer later chooses to give the insurance proceeds to the employee, the payment may be taxable as additional remuneration. An exemption may apply if it is a death gratuity or compensation for death or bodily injury.

Administrative Concession for Group Insurance
For group insurance other than group medical insurance, an employer may elect not to claim a corporate tax deduction for the premiums. If the applicable conditions are satisfied, the premiums will not be taxed in the hands of the employees.

Under this concession:

No advance approval from IRAS is required;
The company must forgo the corporate tax deduction;
The treatment must be applied consistently to all employees covered by the same group policy; and
The company cannot claim a deduction for some employees while excluding the premiums from the taxable income of other employees under the same policy.
The concession is generally not available to:

Investment holding companies;
Tax-exempt bodies; or
Service companies assessed under the cost-plus mark-up basis.
These entities should review whether the premium attributable to each employee or director must be reported as a taxable benefit.

Reporting Insurance Premiums in Form IR8A
Where the premium is taxable, the employer must determine the amount attributable to each insured employee or director.

IRAS accepts a reasonable and consistent allocation method, such as:

Dividing the total premium by the number of employees covered;
Using the actual premium charged for each employee;
Allocating the premium according to each person’s level of coverage; or
Prorating the amount according to the employee’s length of service during the year.
For example, if a company pays a group insurance premium of S$12,000 covering 40 employees for the entire year, it may attribute S$300 to each employee, provided this method reasonably reflects the insurance arrangement.

The company should retain the allocation calculation, insurance schedule and supporting policy documents.

Insurance for Company Directors
For benefit-in-kind purposes, company directors may be treated as employees. Insurance protection provided to a director can therefore be taxable even if the director does not receive a monthly salary.

The following should be reviewed:

Is the director an executive or non-executive director?
Does the director have an employment contract?
Is the insurance part of the director’s remuneration package?
Is the director or the company the beneficiary?
Is the director also a shareholder?
Is the company contractually required to pass the payout to the director?
Does the insurance cover a genuine business risk?
Does the policy have a cash surrender or investment value?
A policy obtained principally for a shareholder-director’s private or family protection may be challenged as a personal expense, especially where it is unrelated to the person’s employment duties.

Keyman Insurance
Keyman insurance protects a business against financial loss arising from the death, disability or incapacity of an important director or employee.

The premium is generally deductible where:

The policy is intended to compensate the company for a loss of trading profits;
The company is the policyholder and beneficiary;
The policy does not provide an investment or savings benefit; and
The insurance is revenue rather than capital in nature.
If the policy compensates the company for lost profits, the insurance proceeds are generally taxable as a revenue receipt.

In contrast, the premium may be non-deductible where the policy:

Is connected to the acquisition of a capital asset;
Protects a company loan or another capital exposure;
Has a cash surrender or investment value; or
Is intended to fund the purchase of a shareholder’s shares.
The name “keyman insurance” is not conclusive. IRAS will consider the purpose and terms of the policy.

Policies With Cash Surrender or Investment Value
Insurance premiums are generally non-deductible when the policy provides:

A cash surrender value;
An investment component;
A savings component;
An endowment benefit; or
Another capital asset belonging to the company.
Such expenditure is capital in nature because the company is acquiring or building up an asset rather than merely paying for insurance protection.

The accounting treatment does not determine the tax outcome. Even if the premium is recorded as an expense in the financial statements, a tax adjustment may be required in the corporate tax computation.

Business Travel Insurance
Travel insurance covering an employee or director during an overseas business trip is generally:

Deductible to the company; and
Not taxable to the employee or director.
The company should retain documents showing the business purpose and travel period.

Insurance covering private holidays or an extended private portion of a trip may need to be apportioned or treated as a taxable personal benefit.

Work Injury Compensation Insurance
Premiums for compulsory work injury compensation insurance are generally deductible because they are incurred in connection with the employer’s statutory liability.

The insurance protection is not treated as a taxable benefit for the employee.

Tax Treatment of Insurance Payouts
The tax treatment of an insurance payout depends on whether the receipt is capital or revenue in nature.

Payout Received by the Company
A payout received by the company is generally:

Taxable where it compensates the company for loss of profits or another revenue item; or
Non-taxable where it represents the realisation of a capital asset or compensation for a capital loss.
Payout Received by an Employee or Director
A payout received by an employee as the intended beneficiary of a life or accident policy is generally capital in nature and is normally not taxable.

However, if the employer was not contractually required to pass the payout to the employee but voluntarily does so, the amount may be treated as additional remuneration.

Death gratuities and consolidated compensation for death or bodily injury may qualify for exemption under the Income Tax Act.

GST Treatment of Staff Insurance Premiums
Corporate income tax deductibility and GST input tax recovery are separate matters.

GST incurred on medical and accident insurance premiums for staff is generally not claimable under Regulation 26 of the GST (General) Regulations.

An exception may apply where the insurance or payment of compensation is obligatory under:

The Work Injury Compensation Act; or
A qualifying collective agreement under the Industrial Relations Act.
Therefore, a premium may be deductible for corporate income tax while the GST charged on the same premium remains blocked.

Refer to the IRAS guidance on conditions for claiming input tax.

Documents Companies Should Keep
Companies should retain the following records for at least five years:

Complete insurance policy;
Policy schedule;
Premium invoice and payment evidence;
Name of the policyholder;
Details of the insured persons;
Name of the beneficiary;
Description of the payout arrangement;
Employment contracts and staff handbook;
Board approval, where applicable;
Explanation of the policy’s business purpose;
Premium allocation for each employee;
Form IR8A reporting records;
Medical expense cap computation; and
Corporate tax adjustments for non-deductible premiums.
The company should not rely only on the insurance policy’s title. The rights of the parties and the commercial purpose of the arrangement determine the correct tax treatment.

Common Tax Mistakes
Common mistakes include:

Claiming all insurance premiums without checking for an investment or surrender value;
Assuming that every group policy is tax-free for employees;
Failing to report premiums benefiting directors in Form IR8A;
Treating a shareholder’s private insurance as a business expense;
Using directors’ fees when calculating the medical expense deduction cap;
Claiming GST on staff medical or accident insurance without checking Regulation 26;
Failing to distinguish between the policyholder and beneficiary;
Applying the group insurance concession inconsistently; and
Treating insurance payouts as automatically non-taxable.
How Ascend Can Assist
Ascend Corporate Service Pte. Ltd. can assist companies with:

Reviewing director and employee insurance policies;
Determining corporate tax deductibility;
Assessing whether premiums are taxable benefits;
Preparing Form IR8A benefit calculations;
Computing the medical expense deduction cap;
Reviewing GST input tax treatment;
Preparing corporate tax adjustments; and
Maintaining supporting tax documentation.
Conclusion
The tax treatment of director and staff insurance depends mainly on four questions:

Who is the policyholder?
Who is entitled to the payout?
Does the policy protect the business or provide a personal benefit?
Does the policy contain an investment or cash surrender value?
Companies should review the actual policy and contractual arrangements before claiming a tax deduction or preparing employees’ income information.

This article is for general information only and does not constitute tax, legal or insurance advice. The appropriate treatment depends on the policy terms, employment arrangements and facts of each case.

31/08/2026

Registration for Multinational Enterprise Top-up Tax and Domestic Top-up Tax in Singapore

Singapore has implemented the Global Anti-Base Erosion (“GloBE”) rules under Pillar Two of the OECD’s international tax framework. The new rules apply to financial years beginning on or after 1 January 2025 and are administered under the Multinational Enterprise (Minimum Tax) Act 2024 (“MMT Act”).

In-scope multinational enterprise (“MNE”) groups with entities in Singapore must determine whether they are required to register with the Inland Revenue Authority of Singapore (“IRAS”) for:

Multinational Enterprise Top-up Tax (“MTT”); and
Domestic Top-up Tax (“DTT”).
Registration is time-sensitive. The registration form must generally be submitted within six months after the end of the MNE group’s first financial year to which the MMT Act applies.

What Are MTT and DTT?
Singapore’s Pillar Two regime is designed to ensure that large MNE groups are subject to a minimum effective tax rate of 15% in each jurisdiction where they operate.

Multinational Enterprise Top-up Tax
MTT implements the Income Inclusion Rule in Singapore. Broadly, it may impose top-up tax on a Singapore parent entity in respect of low-taxed constituent entities located outside Singapore.

Domestic Top-up Tax
DTT may impose additional tax where the effective tax rate of an in-scope MNE group’s Singapore entities is below 15%.

Singapore has implemented MTT and DTT for financial years beginning on or after 1 January 2025. The Undertaxed Profits Rule has not yet been implemented in Singapore.

Which MNE Groups Must Register?
An MNE group is generally required to register under the MMT Act if both of the following conditions are met:

The group has annual revenue of at least €750 million, as reported in the consolidated financial statements of its Ultimate Parent Entity (“UPE”), in at least two of the four financial years immediately preceding the relevant financial year; and
The group has at least one of the following in Singapore:
Constituent Entity, including a permanent establishment;
Joint Venture;
Reverse Hybrid Entity incorporated or registered in Singapore; or
Other entity falling within the registration scope of the MMT Act.
The assessment must be performed at the MNE group level. A Singapore company cannot determine its registration obligation by looking only at its own revenue, profit or tax position.

Registration may still be required even where no top-up tax is ultimately payable, for example because the group qualifies for a safe harbour or its jurisdictional effective tax rate is at least 15%.

Who Is Responsible for Registration?
The UPE is responsible for notifying the Comptroller of Income Tax by submitting the MNE group’s information through the prescribed online registration form.

This applies even when the UPE is incorporated outside Singapore and does not have a Singapore tax identification number.

Alternatively, the UPE may appoint an individual representative to submit the registration on behalf of the group. The representative must be either:

An individual from a constituent entity of the MNE group located in Singapore; or
A local tax agent.
Where a representative is appointed, the registration form must be accompanied by a Letter of Authorisation issued on the UPE’s letterhead. The letter should expressly confirm that the representative’s organisation is authorised to submit the registration and act for both the UPE and the MNE group in registration-related matters.

Registration Deadline
The registration form must be submitted within six months after the end of the MNE group’s first financial year to which the MMT Act applies.

Examples:

First in-scope financial year Registration deadline
1 January 2025 to 31 December 2025 30 June 2026
1 April 2025 to 31 March 2026 30 September 2026
1 July 2025 to 30 June 2026 31 December 2026
For an MNE group with a financial year of less than 12 months that begins and ends in 2025 and is unable to register within six months after its financial year-end, an extension may be requested from IRAS. Such requests are considered on a case-by-case basis.

Information Required for Registration
The MNE group should prepare the following information before submitting the registration form:

1. MNE Group Information
Legal name of the UPE;
UPE’s jurisdiction of incorporation and tax residence;
Group financial year start and end dates;
First financial year to which the MMT Act applies; and
Details of the person submitting the registration.
2. Singapore Entity Information
The tax identification numbers and relevant details of all entities incorporated, registered or located in Singapore, including:

Constituent Entities;
Permanent establishments;
Joint Ventures and Joint Venture subsidiaries;
Minority-owned Constituent Entities;
Investment Entities;
Insurance Investment Entities;
Reverse Hybrid Entities; and
Excluded Entities.
Where the group has more than 30 in-scope entities or more than 30 excluded entities, the applicable IRAS spreadsheet templates should be completed and uploaded instead of entering every entity separately in the online form.

3. Changes in Tax Residence
For an entity incorporated or registered in Singapore that changed its tax residence from Singapore to another jurisdiction after 30 November 2021, the following information is required:

Entity name and tax identification number;
Current jurisdiction of tax residence; and
Effective date of the change in tax residence.
4. Designated Singapore Filing Entity
The MNE group must identify a Singapore Constituent Entity to be appointed as both:

The Designated Local GloBE Information Return Filing Entity (“GFE”); and
The Designated Local DTT Filing Entity (“DFE”).
The registration requires the name and tax identification number of the appointed entity, together with the name, designation and contact details of the relevant contact person.

5. Letter of Authorisation
A Letter of Authorisation is required if the registration is submitted by an appointed representative instead of directly by the UPE.

What Happens After Registration?
IRAS generally aims to process a complete registration within one month. Processing may take longer if information is incomplete or clarification is required.

Once registration is approved:

The MNE group will be assigned a Group Identification Number;
IRAS will issue registration notifications to the relevant responsible members in Singapore; and
The Group ID will subsequently be used for filing the DTT Return and GloBE Information Return through myTax Portal.
If an error is discovered after submitting the registration form, the group should not submit a second registration form. Instead, the acknowledgement number of the original submission should be quoted when contacting IRAS to request a correction.

Consequences of Failing to Register
An in-scope MNE group that fails to notify IRAS of its registration liability may be subject to a surcharge of 10% of the applicable DTT and MTT.

Groups should therefore complete their scope assessment early, confirm the relevant filing entities and obtain the necessary information from the UPE and overseas group entities before the registration deadline.

How Ascend Can Assist
Ascend Corporate Service Pte. Ltd. can assist MNE groups with their Singapore Pillar Two registration and compliance preparations, including:

Reviewing whether the MNE group falls within the registration scope;
Identifying Singapore in-scope and excluded entities;
Preparing the registration information checklist;
Reviewing entity classification and tax residence information;
Coordinating with the UPE and overseas group advisers;
Preparing the Letter of Authorisation;
Assisting with the appointment of the designated Singapore filing entity;
Submitting the registration as an authorised local tax agent; and
Supporting subsequent DTT computation and filing preparations.
Early preparation is particularly important for MNE groups with multiple Singapore entities, changes in tax residence, complex ownership structures or significant differences between their consolidated financial statements and local statutory accounts.

For assistance with MTT and DTT registration in Singapore, please contact Ascend Corporate Service Pte. Ltd.

This article is intended for general information only and does not constitute tax or legal advice. The applicable treatment depends on the MNE group’s structure, financial information and particular circumstances.

Official references: IRAS – Registration for MTT and DTT and IRAS – GloBE Rules and DTT.